TAG ARCHIVE

POSTS TAGGED AS Georgetown University

Urine Test for Bladder Cancer

October 22, 2019 | | Posted in Newsletter

Continuous culture
From a collaboration between cancer researchers at Georgetown University and Fudan University, this piece explains how a “conditional reprogramming” [MORE]

Georgetown’s REMBRANT

October 9, 2018 | | Posted in Newsletter

Bioinformatics
REMBRANT is an acronym for Repository for Molecular Brain Neoplasms Data.  Originally, the National Cancer Institute compiled and organized the [MORE]

“CUSTOM” Molecular Profiling for Clinical Cancer Drug Trials

August 27, 2013 | | Posted in Newsletter

Georgetown University’s Lombardi Comprehensive Cancer Center has conducted the first prospective clinical trial which used genetic analysis alone to [MORE]

ROCK of Ages

February 14, 2012 | | Posted in Newsletter

"ROCK"
A collaborating research group at Georgetown University and the National Institutes of Health has shown that adding Rho kinase [MORE]

“Gene Chip” for Dosing Analysis

February 9, 2010 | | Posted in Newsletter

John Deeken, MD
Recently, The Pharmacogenomics Journal published a study that John Deeken, at Georgetown University’s Lombardi Cancer Center, [MORE]